- Report
- January 2023
- 356 Pages
Global
From €4332EUR$4,950USD£3,766GBP
- Report
- March 2024
- 181 Pages
Global
From €2144EUR$2,450USD£1,864GBP
- Report
- December 2023
- 220 Pages
Global
From €1877EUR$2,145USD£1,632GBP
€2888EUR$3,300USD£2,511GBP
- Report
- October 2023
- 420 Pages
Global
From €1650EUR$1,885USD£1,434GBP
€2538EUR$2,900USD£2,206GBP
- Report
- June 2022
- 1500 Pages
Global
From €2219EUR$2,535USD£1,929GBP
€3413EUR$3,900USD£2,967GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €1707EUR$1,950USD£1,484GBP
€2626EUR$3,000USD£2,282GBP
- Report
- February 2022
- 360 Pages
United States
From €2048EUR$2,340USD£1,780GBP
€3151EUR$3,600USD£2,739GBP
- Report
- November 2021
- 222 Pages
Global
From €1707EUR$1,950USD£1,484GBP
€2626EUR$3,000USD£2,282GBP
- Report
- October 2021
- 78 Pages
Global
From €700EUR$800USD£609GBP
- Report
- May 2024
- 420 Pages
Global
From €1707EUR$1,950USD£1,484GBP
€2626EUR$3,000USD£2,282GBP
- Report
- February 2024
- 50 Pages
Global
From €1365EUR$1,560USD£1,187GBP
€2100EUR$2,400USD£1,826GBP
- Report
- August 2023
- 389 Pages
Global
From €3654EUR$4,175USD£3,176GBP
- Report
- May 2023
United States
From €1313EUR$1,500USD£1,141GBP
- Report
- March 2023
Germany
From €1313EUR$1,500USD£1,141GBP
- Report
- November 2022
- 197 Pages
United States
From €3282EUR$3,750USD£2,853GBP
- Report
- January 2022
- 292 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- November 2024
- 256 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Drug Pipelines
- July 2020
- 33 Pages
Global
From €3063EUR$3,500USD£2,663GBP
- Drug Pipelines
- February 2020
- 96 Pages
Global
From €3063EUR$3,500USD£2,663GBP
- Drug Pipelines
- January 2020
- 112 Pages
Global
From €3063EUR$3,500USD£2,663GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more